[HTML][HTML] Clinical and biological data on the use of hydroxychloroquine against SARS‐CoV‐2 could support the role of the NLRP3 inflammasome in the pathogenesis …
A Lucchesi, P Silimbani, G Musuraca… - Journal of Medical …, 2021 - ncbi.nlm.nih.gov
To the Editor, The use of hydroxychloroquine (HCL) has been very common in countries with
a rapid spread of coronavirus disease 2019 (COVID‐19), although controversial and the …
a rapid spread of coronavirus disease 2019 (COVID‐19), although controversial and the …
CPX-351 daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemia.
A Cafaro, MB Giannini, P Silimbani, D Cangini… - Minerva …, 2020 - europepmc.org
Over the last few years, we assisted to an increasing knowledge about acute myeloid
leukemia (AML) pathobiology. However, outcomes remain unsatisfactory particularly for …
leukemia (AML) pathobiology. However, outcomes remain unsatisfactory particularly for …
[HTML][HTML] Development and validation of an HPLC-DAD method for the simultaneous identification and quantification of topotecan, irinotecan, etoposide, doxorubicin …
S Sanogo, P Silimbani, R Gaggeri, C Masini - Arabian Journal of Chemistry, 2021 - Elsevier
The knowledge of the chemical stability of drugs prepared and administered in hospital is of
paramount importance for establishing the methods and times of their preparation, as well …
paramount importance for establishing the methods and times of their preparation, as well …
Tagraxofusp and anti-CD123 in blastic plasmacytoid dendritic cell neoplasm: a new hope.
D Cangini, P Silimbani, A Cafaro, MB Giannini… - Minerva …, 2020 - europepmc.org
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy,
characterized by poor prognosis if treated with conventional therapy. Allogenic hematologic …
characterized by poor prognosis if treated with conventional therapy. Allogenic hematologic …
[HTML][HTML] Resource utilization and cost saving analysis of subcutaneous versus intravenous trastuzumab in early breast cancer patients
A Farolfi, P Silimbani, D Gallegati, E Petracci… - Oncotarget, 2017 - ncbi.nlm.nih.gov
We conducted an economic evaluation of intravenous (IV) vs subcutaneous (SC)
trastuzumab for the treatment of patients with early breast cancer (EBC). Data of patients …
trastuzumab for the treatment of patients with early breast cancer (EBC). Data of patients …
Antimicrobial prophylaxis in patients with immune thrombocytopenia treated with rituximab: a retrospective multicenter analysis
S Raso, M Napolitano, G Arrigo, F Reale… - Annals of …, 2021 - Springer
The primary aim of this study was to describe the use of primary anti-infective prophylaxis
(AP) in common clinical practice in patients affected by immune thrombocytopenia (ITP) and …
(AP) in common clinical practice in patients affected by immune thrombocytopenia (ITP) and …
Validation of RP-HPLC method to assess the compatibility of metoclopramide and midazolam intravenous mixture used in patients with cancer
S Sanogo, P Silimbani, R Gaggeri, R Rossi… - European Journal of …, 2019 - ejhp.bmj.com
Background The delivery of intravenous medication by continuous infusion is necessary and
widespread for treatment of patients with advanced cancer. Few scientific papers have …
widespread for treatment of patients with advanced cancer. Few scientific papers have …
[HTML][HTML] Recurrent pneumothorax in a patient with liposarcoma as either a complication of lung micrometastasis or a potential adverse event from antibiotic therapy: A …
M Monti, FG Sullo, AP Iamurri, C Gianni… - Oncology …, 2022 - spandidos-publications.com
Spontaneous pneumothorax (PNX) is an infrequent manifestation of primary lung cancer,
soft tissue sarcoma and metastasis. There are no easily accessible data in the literature …
soft tissue sarcoma and metastasis. There are no easily accessible data in the literature …
Consideration on “An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic …
M Monti, P Silimbani, S Ruscelli… - Expert Opinion on Drug …, 2020 - Taylor & Francis
We read with great interest the paper by Bennett et al. published in Expert Opinion on Drug
Safety [1] and appreciated the authorsL attempt to provide a comprehensive overview of the …
Safety [1] and appreciated the authorsL attempt to provide a comprehensive overview of the …
Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/polyamide infusion bags
S Sanogo, P Silimbani, R Gaggeri… - Journal of Oncology …, 2021 - journals.sagepub.com
Purpose Calcium levofolinate (CaLev) for intravenous administration is commercially
available as a powder that must be reconstituted for injection or reconstituted and then …
available as a powder that must be reconstituted for injection or reconstituted and then …